Purpose
Clinical Analysis; Therapeutic Drug Monitoring; Exclusion Screen & Quantitation
Method(s)
High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)
Suggested CPT Code(s)
80342
New York State Approval Status

Approved

Turnaround Time

8 days

Test Includes
1 Loxapine Loxitane® High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 5 Antipsychotic (Neuroleptic)

Specimen Type
Serum or Plasma
Requested Volume
1 mL
Minimum Volume
0.5 mL
Special Handling
Serum: Collect sample in Red top tube
Plasma: Collect sample in Lavender top tube (EDTA) or Pink top tube.
Promptly centrifuge and separate Serum or Plasma into a plastic screw capped vial using approved guidelines.
Specimen Container
Plastic container (preservative-free)

Additional Collection Instructions

Transport Temperature
Refrigerated
Light Protection
Not Required
Rejection Criteria
Polymer gel separation tube (SST or PST).

Rejection criteria pertain to clinical specimen submissions only.

Stability
Room Temperature: 14 day(s)
Refrigerated: 30 day(s)
Frozen (-20 °C): 12 month(s)
1 Loxapine Loxitane® High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 5 Antipsychotic (Neuroleptic)

Interface Map

LOINC® Information